Nivolumab-induced vitiligo successfully treated with narrowband UVB phototherapy

Eur J Dermatol. 2017 Dec 1;27(6):656-658. doi: 10.1684/ejd.2017.3096.

Authors

Takuya Miyagawa¹, Takafumi Kadono², Yuri Masui¹, Daisuke Yamada¹, Ryosuke Saigusa¹, Hiroko Numajiri¹, Jun Omatsu¹, Yoshihide Asano¹, Shinichi Sato¹

Affiliations

¹ Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
² Department of Dermatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa 216-8511, Japan.

PMID: 28739550
DOI: 10.1684/ejd.2017.3096

No abstract available

Publication types

Letter

MeSH terms

Aged
Antibodies, Monoclonal / adverse effects*
Antineoplastic Agents / administration & dosage*
Humans
Male
Melanoma / drug therapy
Melanoma / secondary
Nivolumab
Phototherapy / methods*
Skin Neoplasms / drug therapy
Skin Neoplasms / secondary
Treatment Outcome
Ultraviolet Therapy*
Vitiligo / chemically induced*
Vitiligo / therapy*

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Nivolumab